PL311083A1 - Derivatives of 1,5-bezodiazepine exhibiting antagonistic activity of cck and/or gastrin - Google Patents

Derivatives of 1,5-bezodiazepine exhibiting antagonistic activity of cck and/or gastrin

Info

Publication number
PL311083A1
PL311083A1 PL94311083A PL31108394A PL311083A1 PL 311083 A1 PL311083 A1 PL 311083A1 PL 94311083 A PL94311083 A PL 94311083A PL 31108394 A PL31108394 A PL 31108394A PL 311083 A1 PL311083 A1 PL 311083A1
Authority
PL
Poland
Prior art keywords
bezodiazepine
gastrin
cck
derivatives
antagonistic activity
Prior art date
Application number
PL94311083A
Other languages
English (en)
Inventor
Harry Finch
Pritom Shah
Robin Arthur Ellis Carr
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939307833A external-priority patent/GB9307833D0/en
Priority claimed from GB9406037A external-priority patent/GB9406037D0/en
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of PL311083A1 publication Critical patent/PL311083A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL94311083A 1993-04-15 1994-04-13 Derivatives of 1,5-bezodiazepine exhibiting antagonistic activity of cck and/or gastrin PL311083A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939307833A GB9307833D0 (en) 1993-04-15 1993-04-15 Modulators of cholecystokinin and gastrin
GB9406037A GB9406037D0 (en) 1994-03-29 1994-03-29 1,5 Benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
PL311083A1 true PL311083A1 (en) 1996-02-05

Family

ID=26302765

Family Applications (1)

Application Number Title Priority Date Filing Date
PL94311083A PL311083A1 (en) 1993-04-15 1994-04-13 Derivatives of 1,5-bezodiazepine exhibiting antagonistic activity of cck and/or gastrin

Country Status (14)

Country Link
EP (1) EP0694040A1 (zh)
JP (1) JPH08508743A (zh)
CN (1) CN1120845A (zh)
AU (1) AU688316B2 (zh)
CA (1) CA2158972A1 (zh)
CZ (1) CZ267695A3 (zh)
FI (1) FI954852A (zh)
HU (1) HUT74091A (zh)
NO (1) NO954091L (zh)
NZ (1) NZ265271A (zh)
OA (1) OA10236A (zh)
PL (1) PL311083A1 (zh)
SK (1) SK125495A3 (zh)
WO (1) WO1994024151A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE214056T1 (de) * 1993-12-28 2002-03-15 Shionogi & Co Benzodiazepinderivate
ATE248823T1 (de) * 1996-12-10 2003-09-15 Zeria Pharm Co Ltd 1,5-benzodiazepinderivate
US6444849B1 (en) 1997-06-25 2002-09-03 Mitsubishi Chemical Corporation Amide derivatives
JP2000026434A (ja) 1998-06-05 2000-01-25 Zeria Pharmaceut Co Ltd 新規１，５−ベンゾジアゼピン誘導体
WO2000037434A1 (fr) * 1998-12-22 2000-06-29 Mitsubishi Chemical Corporation Derives d'amide
GB201414116D0 (en) 2014-08-08 2014-09-24 Trio Medicines Ltd Benzodiazepine derivatives
GB201513979D0 (en) 2015-08-07 2015-09-23 Trio Medicines Ltd Synthesis of benzodiazepine derivatives
BR112022006546A2 (pt) 2019-10-07 2022-08-30 Kallyope Inc Agonistas de gpr119

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641280B1 (fr) * 1988-12-29 1994-01-21 Roussel Uclaf Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments
FR2659653B1 (fr) * 1990-03-13 1992-05-22 Rhone Poulenc Sante Derives de l'uree, leur preparation et les medicaments les contenant.
US5206234A (en) * 1990-10-22 1993-04-27 Merck & Co., Inc. Benzolactam analogs as antagonists of cck
GB9201180D0 (en) * 1992-01-21 1992-03-11 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
WO1994024151A1 (en) 1994-10-27
NO954091L (no) 1995-12-13
AU688316B2 (en) 1998-03-12
OA10236A (en) 1997-10-07
CA2158972A1 (en) 1994-10-27
FI954852A0 (fi) 1995-10-12
HUT74091A (en) 1996-11-28
CZ267695A3 (en) 1996-04-17
FI954852A (fi) 1995-10-12
SK125495A3 (en) 1996-06-05
JPH08508743A (ja) 1996-09-17
EP0694040A1 (en) 1996-01-31
HU9502977D0 (en) 1995-12-28
CN1120845A (zh) 1996-04-17
AU6567594A (en) 1994-11-08
NZ265271A (en) 1997-06-24
NO954091D0 (no) 1995-10-13

Similar Documents

Publication Publication Date Title
HK1003943A1 (en) 1,5-benzodiazepine derivatives having cck antagonistic and or agonistic activity
HU9600932D0 (en) In-alkyl-n-arylpyrimidinamines and derivatives thereof
AP9300478A0 (en) 1,5 benzodiazepine derivatives
GR3023258T3 (en) 3-Aryl-4-hydroxy-delta3-dihydrofuranone and 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
NZ248178A (en) Substituted 4-benzoylisoxazole derivatives and herbicidal compositions thereof
ZA921279B (en) Substituted alpha-aminoaldehydes and derivatives
EP0482649A3 (en) Cm-chitin derivatives and use thereof
AU7978794A (en) 3,17-dihydroxy-3,7,16 and/or 17-methyl-androst-5-ene compounds, derivatives thereof, and their use
ZA941926B (en) Heterocyclic compounds their preparation and use
AP9400657A0 (en) 1,5 benzodiazepine derivatives
PL311083A1 (en) Derivatives of 1,5-bezodiazepine exhibiting antagonistic activity of cck and/or gastrin
IL104472A0 (en) Substituted hexahydro-azepinones and tetrahydro-benzazepinones
ZA949293B (en) Hydrazine derivatives and uses thereof
AU3748293A (en) N-{n'-(5-amino-4-hydroxy-acyloyl)-alpha-aminoacyloyl} substituted heterocycles and their use as antiviral agents
GB9403775D0 (en) Hinge arrangements, their construction and use
HU9500177D0 (en) 3-aryluracil derivatives and their use as herbicides
ZA932458B (en) Naphtoquinones and their use.
HU9502057D0 (en) Novel substituted thiosemicarbazone derivatives
GB9308077D0 (en) Assay of 2,4-dinitrophenylhydrazones and related compounds
GB9325420D0 (en) 4'-o-sulfonyl-anthracycline derivatives
PL301984A1 (en) Derivatives of 3-phenyl-5-methylisoxzaole and 4,5-dihydroisoxasole
ZA93143B (en) Piperazinyl derivatives
GB9425776D0 (en) 1,3,5-triazine derivatives,their preparations and uses
ZA947921B (en) In-alkyl-n-arylpyrimidinamines and derivatives thereof
GB2451221B (en) Azidoalkylformals, their prepararion and use